Streetbeat News

Analyst Ratings

PLD

UBS analyst Brent Dilts maintains a Buy rating on Prologis (NYSE:PLD) but lowers the price target from $151 to $138.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:23 pm

ALRN

Aileron Therapeutics' stock price increased following an upgrade by Ladenburg Thalmann, which maintained a Buy rating and raised the price target from $9 to $19. Additionally, the company filed a U.S. Patent Application for 'Methods For Preparing Purified Polypeptide Compositions'.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:18 pm

DECK

TD Cowen analyst John Kernan has maintained a Buy rating on Deckers Outdoor (NYSE:DECK) and increased the price target from $1000 to $1005.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:18 pm

CRI

Citigroup analyst Paul Lejuez has maintained a Sell rating on Carter's (NYSE:CRI) and lowered the price target from $66 to $64.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:16 pm

KNX

TD Cowen analyst Jason Seidl maintains a Buy rating on Knight-Swift (NYSE:KNX) but lowers the price target from $58 to $52.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:15 pm

UAL

United Airlines shares are trading higher following price target upgrades from multiple analysts.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:13 pm

TRV

RBC Capital analyst Mark Dwelle maintains a Sector Perform rating on Travelers Companies (NYSE:TRV) and lowers the price target from $230 to $225.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:12 pm

CRSP

Citigroup analyst Yigal Nochomovitz has maintained a Buy rating on CRISPR Therapeutics (NASDAQ:CRSP) and increased the price target from $88 to $89.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:12 pm

CSX

RBC Capital analyst Walter Spracklin has maintained a 'Sector Perform' rating on CSX Corporation (NASDAQ:CSX) but lowered the price target from $37 to $36.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:03 pm

B

Barnes Group's stock price increased following an upgrade from DA Davidson, changing its rating from Neutral to Buy and raising the price target from $35 to $45.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 4:02 pm